New drug study aims to control debilitating muscle disease

NCT ID NCT06967480

Recruiting now Disease control Sponsor: Alexion Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing whether the drug Ravulizumab can help control symptoms and improve daily life for people with early-stage myasthenia gravis, a condition that causes muscle weakness. Researchers will follow 40 participants for about a year to see how well the drug works in real-world settings, while also looking for biological markers that might predict treatment response. The study focuses on people who have had the disease for three years or less and meet specific medical criteria.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Trial Site
RECRUITING

Bergamo, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Bologna, Italy
Clinical Trial Site
RECRUITING

Bologna, Italy
Clinical Trial Site
RECRUITING

Brescia, Italy
Clinical Trial Site
RECRUITING

Florence, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Imperia, Italy
Clinical Trial Site
RECRUITING

Lecco, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Messina, Italy
Clinical Trial Site
RECRUITING

Milan, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Milan, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Naples, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Novara, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Orbassano, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Padua, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Palermo, Italy
Clinical Trial Site
RECRUITING

Parma, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Pavia, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Pisa, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Roma, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Salerno, Italy
Clinical Trial Site
RECRUITING

San Giovanni Rotondo, 71013, Italy
Clinical Trial Site
RECRUITING

Sassari, Italy
Clinical Trial Site
NOT_YET_RECRUITING

Torino, Italy

Conditions

Explore the condition pages connected to this study.

ANTI-ACHR ANTIBODY POSITIVE GENERALIZED MYASTHENIA GRAVIS